Disease Models & MechanismsGenomicsPeer-reviewed journal article
Noncoding and Coding Mechanisms of Aging Heart Failure with Preserved Ejection Fraction with Thyroid Dysfunction
Sankalpa Chakraborty, Olivia Sloan, Bryce Dickerson, Gourav Chakraborty, Shuang LiiD, Curren Bounds, Sophia Lemus, Caleb Hickman, J. Mauro CalabreseiD, Viswanathan RajagopalaniD
- Citations
- 1
- FWCI
- 0.69
- Field percentile
- top 25%
Abstract
Heart Failure with preserved Ejection Fraction (HFpEF) is a heterogeneous geriatric syndrome with complex pathophysiology and comorbidities. Long noncoding RNAs (lncRNAs) account for a large majority of the functional mammalian transcriptome and act as key regulators in complex physiological and pathological processes. However, the role of lncRNAs and the development of thyroid dysfunction in aging HFpEF is not clear. We investigated the ZSF1 model in both early and more severe stages of HFpEF (5-, 13- and 20-months old [mo]). We assessed molecular, biochemical, and pathophysiological roles involving lncRNAs, mRNAs, and inflammatory markers. Thyroid hormone (TH) immuno-sorbent assays showed significant decreases in serum T3 levels in 5-mo and serum T4 levels in 5-mo and 13-mo obese HFpEF groups compared to lean controls. Morphometric analyses showed significant increases in heart and LV weights in obese HFpEF rats indicating cardiac hypertrophy. LncRNA microarray and RT-qPCR revealed that three key lncRNAs were significantly increased in 13-mo obese HFpEF but not in 5-mo obese HFpEF left ventricles compared to the ZSF1 lean controls. Microarray analyses showed that Sik1 mRNA was significantly upregulated and Anxa13 was downregulated in early obese HFpEF hearts compared to the lean controls. Additionally, we also uncovered previously unreported tissue and serum inflammatory cytokine profiles in early and late HFpEF. This study has identified key novel lncRNA and inflammatory markers in early and late hypothyroid HFpEF. Further studies may help in better understanding and development of diagnostic and therapeutic targets for HFpEF that presents with severe morbidity and mortality.
- organism: rat
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: cell type annotation
- research focus: gene regulatory network inference
- research focus: cell-cell communication
- approach: statistical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrated systems biology identifies disruptions in mitochondrial function and metabolism as key contributors to heart failure with preserved ejection fraction (HFpEF)
Andrew Gibb, Kyle Brian LaPenna, … John W. Elrod·bioRxiv·Oct 25, 2024
- Deciphering human heart failure with preserved ejection fraction (HFpEF) at single cell resolution
Lukas Zanders, Simone-Franziska Glaser, … Stefanie Dimmeler·European Heart JournalPeer-reviewed·Nov 1, 2025
- Time-Resolved Single-Cell Atlas Reveals Early Endothelial Activation and Stage-Dependent Immune-Stromal Communication in HFpEF
Jiantao Gong, Hannah Morgan, … Wei Chieh Huang·bioRxiv·Aug 11, 2026
- Cardiac recovery from pressure overload is not altered by thyroid hormone status in old mice
H. Kerp, J. Gassen, … D. Führer·bioRxiv·Nov 17, 2023
- Targeting Runx1 protects against heart failure with preserved ejection fraction
Ali Ali Mohamed Elbassioni, Anmar Raheem, … Eilidh A. MacDonald·bioRxiv·Jan 24, 2025
- T cell-derived IFNγ instructs ECM crosslinking by cardiac fibroblasts through LOXL3 in experimental cardiometabolic HFpEF
Ramona Emig, Zachary L. Robbe, … Pilar Alcaide·Circulation ResearchPeer-reviewed·Oct 28, 2026